Not yet recruiting
Adenocarcinoma pancreas
Not yet recruitingEfficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer
InvestigationalNo placebo
Efficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer
InvestigationalNo placebo
- Disease:Adenocarcinoma pancreas
- Substances:SIL204
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:SIL204
- Sponsor:Silexion Therapeutics Ltd.
